We've got a low against all the evidence, from my experience the marker of a turning point. With the Science out confirming surrogate endpoints, Dave will be fielding calls from investment houses offering to throw money at SSH. Investment houses will lid the stock at this stage, trying to get a good deal from Dave and feeding in their best customers. Be a while before they go public.